In Brief: Biopharmaceutics
This article was originally published in The Tan Sheet
Executive Summary
Biopharmaceutics: Acquires feminine hygiene product line that includes Koromex, Vaginex, and Feminique from London International U.S. Holdings, the U.S. subsidiary of London International Group. Biopharmaceutics is paying $3.6 mil. for the brands, which generate annual sales of approximately $4 mil. The company announced earlier its letter of intent ("The Tan Sheet" Jan. 22, In Brief)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning